Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma With Portal Vein Thrombosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT06089382
What this trial is testing

Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection

Who this might be right for
Hepatocellular Carcinoma
Tongji Hospital 104
Not applicableUnknownNCT05491889
What this trial is testing

Outcome of Hepatocellular Carcinoma Patients With Portal Vein Thrombosis After Trans-Arterial Chemo Embolization

Who this might be right for
Hepatocellular Carcinoma
Assiut University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07483359
What this trial is testing

Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma (HCC)Portal Vein Tumor Thrombus
First Hospital of China Medical University 38
Not applicableStudy completedNCT06881433
What this trial is testing

Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhongda Hospital 1,649
Not applicableLooking for participantsNCT06622031
What this trial is testing

TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusSystemic Therapy
Sun Yat-sen University 42
Large-scale testing (Phase 3)Study completedNCT02774187
What this trial is testing

Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 247
Testing effectiveness (Phase 2)UnknownNCT06210334
What this trial is testing

HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL)

Who this might be right for
Hepatocellular Carcinoma With PVTT
Li Xiao Wei 54
Large-scale testing (Phase 3)WithdrawnNCT00238160
What this trial is testing

Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer

Who this might be right for
Localized Resectable Adult Primary Liver CancerStage III Childhood Liver Cancer
Kyoto University
Testing effectiveness (Phase 2)Study completedNCT03009461
What this trial is testing

Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis

Who this might be right for
HepatoCellular CarcinomaPortal Vein Thrombosis
Peking University 64
Not applicableUnknownNCT03322280
What this trial is testing

TACE Combined With Iodine-125 Seeds Implantation for HCC

Who this might be right for
Hepatocellular CarcinomaPortal Vein OcclusionTumor Thrombus
Second Affiliated Hospital of Guangzhou Medical University 270
Testing effectiveness (Phase 2)UnknownNCT02452853
What this trial is testing

HR Combined With FOLFOX4 for HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 51
Not applicableStudy completedNCT01556282
What this trial is testing

TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis

Who this might be right for
Liver CancerPortal Vein Thrombosis
Emory University 35
Not applicableStudy completedNCT01177631
What this trial is testing

Proteomic Analysis of Human Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Far Eastern Memorial Hospital 5
Post-approval studies (Phase 4)Ended earlyNCT01600196
What this trial is testing

Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous Thrombus

Who this might be right for
Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Sun Yat-sen University 126
Testing effectiveness (Phase 2)Study completedNCT04945720
What this trial is testing

Hepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT01850368
What this trial is testing

Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombus
Korea Cancer Center Hospital 35
Large-scale testing (Phase 3)Ended earlyNCT04709380
What this trial is testing

Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT

Who this might be right for
RadiotherapyToripalimabSorafenib+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 36
Post-approval studies (Phase 4)Looking for participantsNCT07132515
What this trial is testing

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

Who this might be right for
CirrhosisHCC - Hepatocellular CarcinomaPortal Vein Thrombosis
Mansoura University 100
Testing effectiveness (Phase 2)UnknownNCT04947826
What this trial is testing

Combination Therapy of HAIC and HLX10 and HLX04 in HCC With Major Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma With Major Portal Vein Thrombosis
Shanghai Zhongshan Hospital 100
Large-scale testing (Phase 3)UnknownNCT03192644
What this trial is testing

The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 162
Next Page